Propanc Biopharma enters two loan agreements totaling AUD $120,000 at 12% interest

Propanc Biopharma, Inc.

First loan of AUD $20,000 on June 3, 2024; 12% annual interest; matures June 3, 2025.
Second loan of AUD $100,000 on June 5, 2024; 12% annual interest; matures June 5, 2025.
Both loans for general working capital; company may prepay without penalty.
Loans issued as unregistered securities under Section 4(a)(2) and Rule 506.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.